These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2592582)

  • 1. Pharmacokinetics and efficacy of digoxin specific Fab fragments in a child following massive digoxin overdose.
    Kearns GL; Moss MM; Clayton BD; Hewett DD
    J Clin Pharmacol; 1989 Oct; 29(10):901-8. PubMed ID: 2592582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute massive digoxin overdose: survival without use of digitalis-specific antibodies.
    Springer M; Olson KR; Feaster W
    Am J Emerg Med; 1986 Jul; 4(4):364-8. PubMed ID: 3718631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fab fragments of digoxin-specific antibodies used to reverse ventricular fibrillation induced by digoxin ingestion in a child.
    Zucker AR; Lacina SJ; DasGupta DS; Fozzard HA; Mehlman D; Butler VP; Haber E; Smith TW
    Pediatrics; 1982 Sep; 70(3):468-71. PubMed ID: 7110822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digitalis intoxication and treatment with digoxin antibody fragments in renal failure.
    Erdmann E; Mair W; Knedel M; Schaumann W
    Klin Wochenschr; 1989 Jan; 67(1):16-9. PubMed ID: 2921838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments.
    Wenger TL; Butler VP; Haber E; Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):118A-123A. PubMed ID: 3886748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.
    Smith TW; Butler VP; Haber E; Fozzard H; Marcus FI; Bremner WF; Schulman IC; Phillips A
    N Engl J Med; 1982 Nov; 307(22):1357-62. PubMed ID: 6752715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
    Antman EM; Wenger TL; Butler VP; Haber E; Smith TW
    Circulation; 1990 Jun; 81(6):1744-52. PubMed ID: 2188752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
    Smith TW; Lloyd BL; Spicer N; Haber E
    Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
    Milani L; Bizzaro N; Sanson A
    G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.
    Smith TW; Haber E; Yeatman L; Butler VP
    N Engl J Med; 1976 Apr; 294(15):797-800. PubMed ID: 943040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR; Robert S
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe digoxin intoxication in a 15-year-old girl treated with Fab antidigoxin].
    Gómez Barrado JJ; García Rubira JC; Turégano Albarrán S; García Martínez JT; Trujillo Berraquero F; Molano Casimiro F
    Rev Esp Cardiol; 1996 Apr; 49(4):311-3. PubMed ID: 8650409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin intoxication in a patient with end-stage renal disease: efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis.
    Caspi O; Zylber-Katz E; Gotsman O; Wolf DG; Caraco Y
    Ther Drug Monit; 1997 Oct; 19(5):510-5. PubMed ID: 9357092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe digoxin intoxication in a child treated by infusion of digoxin-specific Fab-antibody-fragments.
    Rossi R; Leititis JU; Hagel KJ; Smolarz A; Brandis M
    Eur J Pediatr; 1984 Jun; 142(2):138-40. PubMed ID: 6468431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication.
    Schaumann W; Kaufmann B; Neubert P; Smolarz A
    Eur J Clin Pharmacol; 1986; 30(5):527-33. PubMed ID: 3758140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin.
    Ujhelyi MR; Robert S; Cummings DM; Colucci RD; Green PJ; Sailstad J; Vlasses PH; Zarowitz BJ
    Ann Intern Med; 1993 Aug; 119(4):273-7. PubMed ID: 8328735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody].
    Sato S
    Kokyu To Junkan; 1989 Oct; 37(10):1055-60. PubMed ID: 2595117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.